These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27808583)

  • 1. A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.
    Gars E; Yousry SM; Babu D; Kurzer JH; George TI; Gratzinger D
    Leuk Lymphoma; 2017 Jul; 58(7):1730-1732. PubMed ID: 27808583
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic.
    Flores-Figueroa E; Gratzinger D
    Int J Mol Sci; 2016 Apr; 17(4):553. PubMed ID: 27089321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
    Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
    Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VCAM-1 expression on bone marrow stromal cells from patients with myelodysplastic syndromes.
    Lubkova ON; Tzvetaeva NV; Momotyuk KS; Belkin VM; Manakova TE
    Bull Exp Biol Med; 2011 May; 151(1):13-5. PubMed ID: 22442792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
    Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated.
    Aanei CM; Catafal LC
    Cytometry A; 2018 Jul; 93(9):916-928. PubMed ID: 30211968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-affinity Nerve Growth Factor Receptor (CD271) Heterogeneous Expression in Adult and Fetal Mesenchymal Stromal Cells.
    Barilani M; Banfi F; Sironi S; Ragni E; Guillaumin S; Polveraccio F; Rosso L; Moro M; Astori G; Pozzobon M; Lazzari L
    Sci Rep; 2018 Jun; 8(1):9321. PubMed ID: 29915318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype.
    Maurizi G; Mattiucci D; Mariani M; Ciarlantini M; Traini S; Mancini S; Olivieri A; Leoni P; Poloni A
    Br J Haematol; 2017 Jun; 177(5):818-822. PubMed ID: 27102230
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes.
    Balaian E; Weidner H; Wobus M; Baschant U; Jacobi A; Mies A; Bornhäuser M; Guck J; Hofbauer LC; Rauner M; Platzbecker U
    Ann Hematol; 2019 Sep; 98(9):2063-2072. PubMed ID: 31312928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zhao Y; Wu D; Fei C; Guo J; Gu S; Zhu Y; Xu F; Zhang Z; Wu L; Li X; Chang C
    Haematologica; 2015 Feb; 100(2):194-204. PubMed ID: 25361944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes.
    Ping Z; Chen S; Hermans SJF; Kenswil KJG; Feyen J; van Dijk C; Bindels EMJ; Mylona AM; Adisty NM; Hoogenboezem RM; Sanders MA; Cremers EMP; Lindenbergh-Kortleve DJ; Samsom JN; van de Loosdrecht AA; Raaijmakers MHGP
    Leukemia; 2019 Feb; 33(2):536-541. PubMed ID: 30315231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow niche in the myelodysplastic syndromes.
    Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
    Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of the CD271+ and CD271- mesenchymal stromal cell enrichment toward nucleus pulposus-like cells.
    Jezierska-Wozniak K; Barczewska M; Habich A; Wojtacha P; Badowska W; Maksymowicz W; Wojtkiewicz J
    Folia Histochem Cytobiol; 2017; 55(3):114-123. PubMed ID: 28925497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival.
    Johnson RC; Kurzer JH; Greenberg PL; Gratzinger D
    Am J Clin Pathol; 2014 Dec; 142(6):795-802. PubMed ID: 25389333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.
    Jann JC; Mossner M; Riabov V; Altrock E; Schmitt N; Flach J; Xu Q; Nowak V; Obländer J; Palme I; Weimer N; Streuer A; Jawhar A; Darwich A; Jawhar M; Metzgeroth G; Nolte F; Hofmann WK; Nowak D
    Nat Commun; 2021 Oct; 12(1):6170. PubMed ID: 34697318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
    Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A
    Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1α expression indicates poor prognosis in myelodysplastic syndromes.
    Tong H; Hu C; Zhuang Z; Wang L; Jin J
    Leuk Lymphoma; 2012 Dec; 53(12):2412-8. PubMed ID: 22632108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical picture and morphocytochemical characteristics of the cells in an idiopathic myelodysplastic syndrome].
    Turbina NS; Shishkanova ZG; Zakharova AV; Ustinova EN; Shakhbazian GP; Miterev GIu; Diagileva OA; Glasko EN; Kozinets GI
    Gematol Transfuziol; 1995; 40(6):41-4. PubMed ID: 8666192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.